Alkem Laboratories has informed that a meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2016, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2016.
The above information is a part of company’s filings submitted to BSE.